Loading company…
Private securities offering disclosed via SEC Form D.
Renovare Therapeutics, Inc. filed a Form D notice of exempt offering with the SEC.
1 round · latest Private placement (Form D), Sep 2026 · $100K raised
Sign in to see 1 rounds.
Sign inNo investors recorded yet for Renovare Therapeutics, Inc..
Add an investorSign in to see 1 more people.
Renovare Therapeutics, Inc. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Renovare Therapeutics, Inc..
Add diversity data